Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase NA 3Phase 3 2Phase 4 1Phase 2/3 1

Status

Terminated 1Active not recruiting 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2Other 1

Conditions

Thyroid Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Radiation Injuries 1Pain 1Mucositis 1Head and Neck Neoplasms 1

Interventions

Cisplatin 144Radiotherapy 71Fluorouracil 50Radiotherapy, Intensity-Modulated 45Docetaxel 39Gemcitabine 38Cetuximab 38Carboplatin 31pembrolizumab 25Capecitabine 22Drug Therapy 17toripalimab 14Paclitaxel 14camrelizumab 10Surgical Procedures, Operative 10Nivolumab 10Chemoradiotherapy 10nimotuzumab 9Radiation 9Neoadjuvant Therapy 8Methotrexate 8Magnetic Resonance Spectroscopy 8Chemotherapy, Adjuvant 8nedaplatin 7Thyrotropin Alfa 7Platinum 7tislelizumab 6spartalizumab 6Standard of Care 6Specimen Handling 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Neck Dissection × Head & Neck × Clear all
NCT03570021 2026-03-06

ESTIMABL3

Gustave Roussy, Cancer Campus, Grand Paris

Phase 3 Active not recruiting
352 enrolled
Head & Neck

Thyroid Neoplasms

NCT00360971 2017-12-26

Palifermin in Lessening Oral Mucositis in Patients Undergoing Radiation Therapy and Chemotherapy for Locally Advanced Head and Neck Cancer

Radiation Therapy Oncology Group

Phase 3 Terminated
21 enrolled 10 charts
Head & NeckOther

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Pain, Radiation Injuries, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡